Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin

  1. Charles Keller1,
  2. Mark S. Hansen1,
  3. Cheryl M. Coffin2, and
  4. Mario R. Capecchi3,4
  1. 1Division of Pediatric Hematology-Oncology, Department of Pediatrics, 2Division of Pediatric Pathology, Department of Pathology, and 3Howard Hughes Medical Institute and Department of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA

Abstract

To investigate the role of the translocation-associated gene Pax3:Fkhr in alveolar rhabdomyosarcomas, we generated a Cre-mediated conditional knock-in of Pax3:Fkhr into the mouse Pax3 locus. Exploring embryonic tumor cell origins, we replaced a Pax3 allele with Pax3:Fkhr throughout its expression domain, causing dominant-negative effects on Pax3 and paradoxical activation of the Pax3 target gene, c-Met. Ectopic neuroprogenitor cell proliferation also occurs. In contrast, activation later in embryogenesis in cells that express Pax7 results in viable animals with a postnatal growth defect and a moderately decreased Pax7+ muscle satellite cell pool, phenocopying Pax7 deficiency but remarkably not leading to tumors.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1243904.

  • 4 Corresponding author. E-MAIL mario.capecchi{at}genetics.utah.edu; FAX (801) 585-3425.

    • Accepted September 3, 2004.
    • Received July 26, 2004.
| Table of Contents

Life Science Alliance